
Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.

Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.

This review summarizes the safety and efficacy of 3 new orally active anticoagulant drugs (dabigatran, rivaroxaban, apixaban) that can be used as alternatives to warfarin.

Published: July 19th 2025 | Updated:

Published: December 11th 2012 | Updated: